Background and Objectives:
We aimed to determine the prevalence of poststroke depression (PSD) and anxiety as well as to identify their predictors in a population of young Filipino adults.
Methods:
We performed a cross-sectional epidemiologic study in the largest tertiary hospital in the Philippines. The study involved the administration of a structured survey tool and review of medical records. The Hospital Anxiety and Depression Score was used to screen for anxiety and depression. Chi-square tests and Fisher’s exact tests were used to compare between groups with anxiety or depression and those without. Multivariable logistic regression analysis was performed to determine significant socio-economic and clinical risk factors of PSD and anxiety.
Results:
In our study population of 114 young adult stroke patients, the prevalence of depression was 20.2% while the prevalence of anxiety was 34.2%. Significant predictors of PSD were the presence of anxiety (OR 1.84; CI 1.05-3.22), lower mRS scores (mRS 3-5 OR 5.52; 95% CI 1.09-8.03) and diabetes (OR 2.09; 95% CI 1.67-6.26). Meanwhile, significant predictors of poststroke anxiety included depression (OR 7.5; 95% CI 5.02-21.94) and dependence (Barthel Index scores 95-100; OR 0.32; 95% CI 0.14-0.71). Relationship status, educational attainment, stroke subtype and stroke location were not found to be significant predictors of PSD and anxiety.
Conclusion:
Our study showed that young adult patients who suffer from stroke are at risk for adverse socio-economic and psychiatric consequences. A significant proportion of the population had depression and anxiety after stroke. Clinicians should be aware of these conditions that influence the outcomes of young adult stroke patients.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.